UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________
Form 6-K
________________________________
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
February 22, 2016
________________________________
Lombard Medical, Inc.
(Exact Name of Registrant as Specified in Its Charter)
________________________________
N/A
(Translation of Registrant’s Name into English)
________________________________
Cayman Islands | 3841 | Not applicable |
(State or Other Jurisdiction of | (Primary Standard Industrial | (I.R.S. Employer |
Incorporation or Organization) | Classification Code Number) | Identification Number) |
| 6440 Oak Canyon | |
| Suite 200 | |
| Irvine, CA 92618 | |
| +866-790-1447 | |
(Address, Including ZIP Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)
________________________________
Lombard Medical, Inc.
6440 Oak Canyon
Suite 200
Irvine, CA 92618
(Name, Address of Agent for Service)
________________________________
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-FX Form 40-F
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):o
On February 22, 2016, Lombard Medical, Inc. publicly published unaudited quarterly financial information for the fourth quarter and year ended December 31, 2015, contained in Exhibit 99.1 to this Report on Form 6-K.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | Lombard Medical, Inc. |
| | |
| | By: | /s/ William J. Kullback |
| | | |
| | | William J. Kullback |
| | | Chief Financial Officer |
| | |
Date: February 22, 2016 | | |